Lotus Diabetes Private Limited, a converted to llp private limited company, was established on 21 March 2012 in Delhi, Delhi, India. Engaging in preventive health services within the hospital and medical care sector, it holds CIN: U74900DL2012PTC233210. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.15 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Preeti Handa Singhal (Director), Sandeep Singhal (Director), Ajay Kumar Gupta (Director). Past directors included Preeti Handa Singhal, Ajay Kumar Gupta. Its latest AGM occurred on 25 September 2024, with the balance sheet filed on 31 March 2024. It is based at 193A, Pocket A, Mayur Vihar Phase -Ii, Delhi, Delhi, 110091.
U74900DL2012PTC233210
233210
21 March 2012
₹0.15 M
₹0.10 M
Roc Delhi
Unlisted
Converted to LLP
Explore comprehensive insights into Lotus Diabetes Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Preeti Handa Singhal | Director | 01 Oct 2014 | Current |
| Sandeep Singhal | Director | 21 Mar 2012 | Current |
| Ajay Kumar Gupta | Director | 21 Apr 2017 | Current |
| Rupesh Kapoor | Director | 21 Mar 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 26 Sep 2015 | Past |
| Pramod Abcsdd | Additional Director | 26 Sep 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Lotus Diabetes Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Lotus Diabetes had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Lotus Diabetes, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Lotus Diabetes, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lotus Diabetes's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Lotus Diabetes Private Limited last Annual general meeting of members was held on 25 Sep 2024 as per latest MCA records. was documented.
Lotus Diabetes Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
The activity Ajay Kumar Gupta was appointed as a Director was appointed as a Director on 21 Apr 2017 & has been associated with this company since 8 years 7 months . was completed.
The activity Preeti Handa Singhal was appointed as a Director was appointed as a Director on 01 Oct 2014 & has been associated with this company since 11 years 1 month . was completed.
The activity Sandeep Singhal was appointed as a Director was appointed as a Director on 21 Mar 2012 & has been associated with this company since 13 years 8 months . was completed.
Progress on Rupesh Kapoor was appointed as a Director was appointed as a Director on 21 Mar 2012 & has been associated with this company since 13 years 8 months . was documented.
The CIN of Lotus Diabetes Private Limited is U74900DL2012PTC233210.
Lotus Diabetes Private Limited is headquartered at 193A, Pocket A, Mayur Vihar Phase -Ii, Delhi, Delhi, 110091.
Lotus Diabetes Private Limited was incorporated on 21 March 2012.
The current directors of Lotus Diabetes Private Limited are
The primary industry of Lotus Diabetes Private Limited is Hospital And Medical Care.
Lotus Diabetes Private Limited is unlisted.
The authorized capital of Lotus Diabetes Private Limited is ₹0.15 M, and the paid-up capital is ₹0.10 M.
The compliance status of Lotus Diabetes Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX